A new study has revealed that a drug used for migraines may increase the risk of miscarriage in the early months of pregnancy. These drugs, called calcitonin gene-related peptide (CGRP) monoclonal antibodies, are given in the form of injections and have been shown to be effective in preventing attacks in about 50 percent of migraine The post Migraine medication may increase risk of miscarriage: Research appeared first on Daily The Patriot.



